(Q36237524)

12 August 2017

1 reference

title

Emerging drug targets for antiretroviral therapy (English)

1 reference

12 August 2017

Jacqueline D Reeves

1

1 reference

12 August 2017

Andrew J Piefer

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

65

1 reference

12 August 2017

issue

13

1 reference

12 August 2017

page(s)

1747-1766

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565130-00002

12 August 2017

exact match

0 references

cites work

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

1 reference

12 December 2020

The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes

1 reference

12 December 2020

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

1 reference

12 December 2020

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

12 December 2020

Restriction of lentivirus in monkeys

1 reference

12 December 2020

Cell type-dependence for Vpu function

1 reference

12 December 2020

Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection

1 reference

12 December 2020

The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding

1 reference

12 December 2020

New nucleoside/nucleotide backbone options: a review of recent studies

1 reference

12 December 2020

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

12 December 2020

A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase

1 reference

12 December 2020

Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo

1 reference

12 December 2020

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

1 reference

12 December 2020

The sor gene of HIV-1 is required for efficient virus transmission in vitro

1 reference

12 December 2020

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

1 reference

12 December 2020

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

12 December 2020

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

1 reference

12 December 2020

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

12 December 2020

Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

1 reference

12 December 2020

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

12 December 2020

Positional cloning of the mouse retrovirus restriction gene Fv1.

1 reference

12 December 2020

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

12 December 2020

Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20).

1 reference

12 December 2020

The Protein Network of HIV Budding

1 reference

12 December 2020

1 reference

12 December 2020

Resistance to enfuvirtide, the first HIV fusion inhibitor

1 reference

12 December 2020

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

12 December 2020

Blocking the docking of HIV-1.

1 reference

12 December 2020

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor

1 reference

12 December 2020

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus

1 reference

12 December 2020

Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

1 reference

12 December 2020

AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding

1 reference

12 December 2020

Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

1 reference

12 December 2020

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

12 December 2020

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

12 December 2020

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

1 reference

12 December 2020

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

1 reference

12 December 2020

Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses

1 reference

12 December 2020

Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.

1 reference

12 December 2020

Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation

1 reference

12 December 2020

HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process

1 reference

12 December 2020

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

12 December 2020

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication

1 reference

12 December 2020

Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor.

1 reference

12 December 2020

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

1 reference

12 December 2020

Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.

1 reference

12 December 2020

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro

1 reference

12 December 2020

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

12 December 2020

Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity

1 reference

12 December 2020

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

1 reference

12 December 2020

Fv1, the mouse retrovirus resistance gene

1 reference

12 December 2020

Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update

1 reference

12 December 2020

Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques

1 reference

12 December 2020

Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins

1 reference

12 December 2020

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

12 December 2020

Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor

1 reference

12 December 2020

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

12 December 2020

CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo

1 reference

12 December 2020

HIV-1 gp41 as a target for viral entry inhibition

1 reference

12 December 2020

Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging

1 reference

12 December 2020

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

1 reference

12 December 2020

Preventing HIV-1 sexual transmission--not sexy enough science, or no benefit to the bottom line?

1 reference

12 December 2020

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

1 reference

12 December 2020

Microbicides--aids to safer sex

1 reference

12 December 2020

Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection

1 reference

12 December 2020

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)

1 reference

12 December 2020

The entry of entry inhibitors: a fusion of science and medicine

1 reference

12 December 2020

Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition

1 reference

12 December 2020

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

12 December 2020

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry

1 reference

12 December 2020

CD4 down-modulating compounds with potent anti-HIV activity

1 reference

12 December 2020

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

12 December 2020

Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.

1 reference

12 December 2020

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1

1 reference

12 December 2020

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

1 reference

12 December 2020

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.

1 reference

12 December 2020

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

12 December 2020

Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein

1 reference

12 December 2020

HIV-1 membrane fusion: targets of opportunity

1 reference

12 December 2020

Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1

1 reference

12 December 2020

Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag.

1 reference

12 December 2020

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

1 reference

12 December 2020

Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites

1 reference

12 December 2020

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

12 December 2020

DNA deamination mediates innate immunity to retroviral infection

1 reference

12 December 2020

Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment

1 reference

12 December 2020

Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion

1 reference

12 December 2020

Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.

1 reference

12 December 2020

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

12 December 2020

The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission.

1 reference

12 December 2020

Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion

1 reference

12 December 2020

Human immunodeficiency virus type 2

1 reference

12 December 2020

Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue

1 reference

12 December 2020

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

1 reference

12 December 2020

CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor

1 reference

12 December 2020

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

12 December 2020

The bicyclam AMD3100 story

1 reference

12 December 2020

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

12 December 2020

HIV protease inhibition: limited recent progress and advances in understanding current pitfalls

1 reference

12 December 2020

Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

1 reference

12 December 2020

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

1 reference

12 December 2020

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

1 reference

12 December 2020

HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro

1 reference

12 December 2020

A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties

1 reference

12 December 2020

Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway

1 reference

12 December 2020

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

12 December 2020

Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro

1 reference

12 December 2020

Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.

1 reference

12 December 2020

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

1 reference

12 December 2020

Inhibiting sexual transmission of HIV-1 infection

1 reference

12 December 2020

Prospects of HIV-1 entry inhibitors as novel therapeutics

1 reference

12 December 2020

Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization

1 reference

12 December 2020

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

1 reference

12 December 2020

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

1 reference

12 December 2020

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

1 reference

12 December 2020

The barrier-to-autointegration protein is a host factor for HIV type 1 integration

1 reference

12 December 2020

Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release

1 reference

12 December 2020

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

12 December 2020

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

12 December 2020

Clinical development of microbicides for the prevention of HIV infection

1 reference

12 December 2020

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

12 December 2020

A nucleoprotein complex mediates the integration of retroviral DNA.

1 reference

12 December 2020

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

1 reference

12 December 2020

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

12 December 2020

Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.

1 reference

12 December 2020

A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion

1 reference

12 December 2020

Potential new therapies for the treatment of HIV-1 infection

1 reference

12 December 2020

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

12 December 2020

Integrating DNA: transposases and retroviral integrases

1 reference

12 December 2020

Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155.

1 reference

12 December 2020

Chemokine receptors and HIV entry

1 reference

12 December 2020

The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid

1 reference

12 December 2020

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

1 reference

12 December 2020

Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team

1 reference

12 December 2020

HIV-1 attachment: another look.

1 reference

12 December 2020

Antiretroviral resistance testing comes of age

1 reference

12 December 2020

Function of human immunodeficiency virus type 1 Vpu protein in various cell types.

1 reference

12 December 2020

Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

1 reference

12 December 2020

Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors

1 reference

12 December 2020

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

12 December 2020

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

1 reference

12 December 2020

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

1 reference

12 December 2020

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

12 December 2020

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells

1 reference

12 December 2020

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

1 reference

12 December 2020

Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production

1 reference

12 December 2020

Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

1 reference

12 December 2020

Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides

1 reference

12 December 2020

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

12 December 2020

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

1 reference

12 December 2020

Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance

1 reference

12 December 2020

HIV fusion and its inhibition in antiretroviral therapy

1 reference

12 December 2020

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities

1 reference

12 December 2020

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

1 reference

12 December 2020

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models

1 reference

12 December 2020

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

HIV: replication trimmed back

1 reference

12 December 2020

Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells

1 reference

12 December 2020

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

12 December 2020

The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor

1 reference

12 December 2020

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

12 December 2020

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

1 reference

12 December 2020

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

12 December 2020

HIV co-receptors as targets for antiviral therapy

1 reference

12 December 2020

A conserved mechanism of retrovirus restriction in mammals

1 reference

12 December 2020

Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors

1 reference

12 December 2020

Antiretrovirals, part 1: overview, history, and focus on protease inhibitors

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

12 December 2020

Trim5alpha protein restricts both HIV-1 and murine leukemia virus

1 reference

12 December 2020

CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor

1 reference

12 December 2020

The HIV 'A' (sor) gene product is essential for virus infectivity

1 reference

12 December 2020

HIV-1 entry inhibitors: closing the front door

1 reference

12 December 2020

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity

1 reference

12 December 2020

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

12 December 2020

Restriction factors: a defense against retroviral infection

1 reference

12 December 2020

HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches

1 reference

12 December 2020

'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo.

1 reference

12 December 2020

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha

1 reference

12 December 2020

Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.

1 reference

12 December 2020

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

1 reference

12 December 2020

Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions

1 reference

12 December 2020

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities

1 reference

12 December 2020

Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.

1 reference

12 December 2020

Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

1 reference

12 December 2020

Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.

1 reference

12 December 2020

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

12 December 2020

Specific CD4 down-modulating compounds with potent anti-HIV activity

1 reference

12 December 2020

Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase

1 reference

12 December 2020

HIV transmission: closing all the doors

1 reference

12 December 2020

Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes

1 reference

12 December 2020

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

12 December 2020

HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro

1 reference

12 December 2020

Evidence for a newly discovered cellular anti-HIV-1 phenotype

1 reference

12 December 2020

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

1 reference

12 December 2020

Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins

1 reference

12 December 2020

Co-receptor antagonists as HIV-1 entry inhibitors.

1 reference

12 December 2020

HIV resistance to the fusion inhibitor enfuvirtide: mechanisms and clinical implications

1 reference

12 December 2020

10.2165/00003495-200565130-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1043805131

0 references

1 reference